HEALTH OF WOMAN. 2019.8(144): 53–56; doi 10.15574/HW.2019.144.53
Vl.V Podolsky, V.V Podolsky
Institute of pediatrics, obstetrics and ginecology named academic Elena M. Lukyanova NAMS of Ukraine

The therapeutic use of various materials has long been known in medical practice. The use of polymers in dental surgery, eye surgery, heart surgery and other areas today is widespread in most countries. Substances that interact with human cells are called biomaterials. However, many issues of the interaction between human cells and synthesized materials remain unresolved, for example, such as compatibility and degradation in the case of prosthetics. The development of combined materials containing human proteins or cells and complex polymers is a promising industry in the development of medicine.

The extracellular matrix (ECM) is an auxiliary substance for each cell of the human body, contains proteins and macromolecules. Substances derived from ECM are now widely used as biomaterials, such as collagen and hyaluronic acid.

A large number of studies on the effect of hyaluronic acid on the human body, allowed us to determine its main properties, due to which hyaluronic acid is widely used in the medical, pharmaceutical and cosmetic industries, namely, for its high bioavailability, degradability, and lack of response of the immune system to this compound, as well as for its viscoelasticity. Such properties of hyaluronic acid provide the possibility of its use in obstetric and gynecological practice.

Vaginal suppositories with hyaluronic acid and medicinal plants are becoming popular because they are safe and effective, which doctors and patients pay attention to.

The preparations Gial-Eroz and Gial-Meno, which are presented in the form of suppositories, are the optimal dosage form for intravaginal use. The use of Gial-Eroz and Gial-Meno drugs, which have various mechanisms for restoring the vaginal mucosa, can be an effective part of complex therapy in women with cervical erosion and atrophic vaginitis.

Key words: cervical erosion, vaginal atrophy, women, hyaluronic acid, vitamins, postmenopausal period, Gial-Eroz, Gial-Meno.

REFERENCES

1. Appel Erik A, Meyer EU, Langer Robert, Uebber, Metyu Dzh, Appel Erik A, Meyer EU. 2016. Supramolekulyarnyie biomaterialyi. Prirodnyie materialy 15(1): 13-26.

2. Langer R, Tirrell DA. 2004. Razrabotka materialov dlya biologii i meditsinyi. Priroda 428 (6982): 487-92.

3. Huebsch N & Mooney DJ. 2009. Vdohnovenie i primenenie v evolyutsii biomaterialov. Nature. 462,426–432

4. Devis ME i Bryuster ME. 2004. Farmatsevticheskaya produktsiya na osnove tsiklodekstrina: proshloe, nastoyaschee i buduschee. NatureRev. DrugDiscov. 3:1023–1035.

5. Rodell SB, Kaminski A i Burdik DzhA. 2013. Ratsionalnoe proektirovanie svoistv seti v gidrogelyah gialuronovoy kisloty, sobrannyh po tipu «gost – hozyain», i razzhizhayuschihsya pri sdvige. Biomakromolekulyiyu 14:4125–4134.

6. Park KM i soavt. 2012. V situsupramolekulyarnoy sborke i modulnoy modifikatsii gidrogeley gialuronovoy kisloty dlya trehmernoy kletochnoy inzhenerii. ACS Nano. 6:2960–2968.

7. Nissen FB, Spauven PHM, Shalkveyk Y, Kon M. 1999. O prirode gipertroficheskih rubtsov i keloidov: obzor. PlastRecSurg. Vyip. 104: 1435–1448.

8. Chzhan Q, Kelli AP, Van L, French SV, Tan H, Duong HS, Messadi DV, Le AD. 2006. Ekstrakt zelenogo chaya i (-)-epigallokatehin-3-gallat ingibiruyut stimulirovannuyu tuchnyimi kletkami ekspressiyu kollagena I tipa v keloidnyh fibroblastah posredstvom blokirovaniya signalnyih putey PI-3K / AkT. J. Invest. Dermatol. Vyip. 126;12:2607–2613.

9. Kostantini, Lazzeri, Tsukki, Porena. 2008. Lechenie narusheniy zazhivleniya posle vypadeniya organov bryushnoy polosti. Evropeyskie dopolneniya urologii 7 (3): 288.

10. Falsaperla, Bonakkorsi, Kaldarella, Salerno, Russo, Motta i dr. 2008. Otkryitaya abdominalnaya sakrokolpopeksiya: sravnitelnoe randomizirovannoe issledovanie, sravnivayuschee sinteticheskuyu polipropilenovuyu setku i beskletochnyiy kollagenovyiy biomesh (pelvicoltm). Evropeyskie dopolneniya urologii 7(3): 288.

11. Singh L, Kryuger HG, Maguayr DzhM, Govender T, Parbousing R. 2017. Rol nanotehnologiy v lechenii virusnyih infektsiy. Terapevticheskie dostizheniya v oblasti infektsionnyh zabolevaniy 4 (4): 105-31.

12. Vasnik G, Dzhayn K, Husaini G, Bansal F. 2019. Korrelyatsiya ploskokletochnyh intraepitelialnyih porazheniy sheyki matki s virusom papillomyi cheloveka u zhenschin, infitsirovannyih virusom immunodefitsita cheloveka. Indiyskiy zhurnal ginekologicheskoy onkologii 17(1): 1-8.

13. Harbhajanka A, Chahar S, Michael CW. 2019. Patologicheskiy rezultat testov ThinPrepPap, diagnostirovannyh kak anomalii zhelezistyh kletok, po sravneniyu s kombinirovannymi zhelezistymi i ploskokletochnymi anomaliyami. Diagnosticheskaya tsitopatologiya 47(2): 88-93.

14. Tateyama N, Asakura H, Takeshita T. 2013. Korrelyatsiya mezhdu otsutstviem oblasti sheynoy zhelezyi pri transvaginalnoy sonografii i urovnem gialuronovoy kislotyi slizistoy sheiki matki u zhenschin s ugrozoi prezhdevremennyh rodov. Zhurnal perinatalnoy meditsiny 41(2): 151-7.

15. Ziaei S, Kazemnejad A, Zareai M. 2007. Vliyanie vitamina E na prilivyi u zhenschin v period menopauzyi. GinekolObstet Invest. 64 (4): 204-7.

16. McLaren H. 1949. Vitamin E v menopauze. Britanskiy meditsinskiy zhurnal 2: 1378–1381.

17. Ziagam S, Abbaspur Z, Safyari S, Rad R. 2013. Vliyanie vaginalnogo suppozitoriya s vitaminom E na atroficheskiy vaginit u zhenschin v postmenopauze. Zhurnal hronicheskih zabolevaniy Zhundishapur. 2(4): 11-19.

18. Parnan Emamverdihan A, Golmakani N, Sharifi Sistani N, Tagi Shakeri M, Hasanzade Mofrad M, Sadzhadi Tabassi A. 2014. Sravnenie dvuh metodov lecheniya suppozitoriem s vitaminom E i kon'yugirovannyim estrogenom vlagalischnogo krema na Kachestvo zhizni u zhenschin v period menopauzyi s vaginalnoy atrofiey. Zhurnal akusherstva i reproduktivnogo zdorovya 2(4): 253-261. doi: 10.22038 / jmrh.2014.3246

19. Lima SM, Yamada SS, Reys BF, Postigo S, Galvao da Silva MA, Aoki T. 2013. Effektivnoe lechenie vaginalnoy atrofii izoflavonovyim vaginalnyim gelem. Maturitas. 71(3): 252-258.

20. Huan ADzh, Mur EE, Boyko EDzh, Skoulz D, Lin F, Vittinghoff E i dr. 2010. Vaginalnyie simptomy u zhenschin v postmenopauze: samootsenka tyazhesti, estestvennaya istoriya i faktory riska. Menopaus. 17(1): 121-126.

21. Veerus P, Fisher K, Hovi SL, Karro N, Rahu M, Hemminki E. 2008. Soobschenie o simptomah i kachestve zhizni v estonskom ispyitanii posle menopauzalnoy gormonoterapii. BMC WomensHealthJournal 8(1): 5.

22. Kastelo-Branko S, Kanchelo M, Villero G, Nohales F, Dzhuli M. 2005. Upravlenie postmenopauzalnoy vaginalnoy atrofiey i atroficheskim vaginitom. Evropeyskiy zhurnal menopauzy 52(1): 46–52.

23. Nayar R Uilbur, okrug Kolumbiya. 2015, may. Pap-test i Bethesda 2014. Rak tsitopatol. 123 (5): 271-81.

24. Mirzamani N, Chau K, Rafael O, Shergill Yu, Sadzhan S, Sumskaya I, Gimenes S. Kleyn M, Das K. 2017, Okt. Otsenka kachestva i uluchshenie «neudovletvoritelnyih» zhidkih mazkov iz sheyki matki vlagalischnogo tipa. Diagnostika tsitopatol. 45(10): 873-877.

25. Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, Perrotta M, Prendiville W, Russell P, Sideri M, Strander B, Tatti S, Torne A, Walker P. 2011. Kolposkopicheskaya terminologiya Mezhdunarodnoy federatsii dlya patologii sheyki matki i kolposkopii. Obstet Gynecol. 120(1): 166-72. 2012, iyul.

26. Laffleur F. 2018. Comparative mucoadhesive study of hyaluronic acid-based conjugates on different mucosae. Journal of Applied Polymer Science. 135(14):n/a. https://doi.org/10.1002/app.46071

27. Hersant BP, SidAhmed-Mezi M, Belkacemi Y, Darmon F, Bastuji-Garin S, Werkoff G et al. 2018. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 25(10). https://doi.org/10.1097/GME.0000000000001122; PMid:29738415

28. Reiter S. 2013. Barriers to effective treatment of vaginal atrophy with local estrogen therapy. Int J Gen Med 6:153-158. https://doi.org/10.2147/IJGM.S43192; PMid:23525842 PMCid:PMC3603331

29. Pallast, Schouten, de Waart, Fonk, Doekes, Von Blomberg et al. 1999. Effect of 50- and 100 mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. The American journal of clinical nutrition. 69(6):1273–81. https://doi.org/10.1093/ajcn/69.6.1273; PMid:10357750

30. Kira EF. 2012. Bakterialnyiy vaginoz. M, OOO «Meditsinskoe informatsionnoe agentstvo»:472.